Scientific Clinical Trials
Purpose
To provide strategic oversight, scientific review, origination, initiation, and prioritisation of international clinical trials in head and neck cancer under the HNCIG umbrella.
Scope of Work
- Originate and initiate clinical trial concepts.
- Review, endorse, and prioritise proposed clinical trial concepts.
- Ensure trials are scientifically rigorous, feasible, and align with HNCIG’s mission.
- Advise on trial design, endpoints, and methodology.
- Facilitate collaboration across member groups for multi-country participation and with industry.
- Oversee ongoing trials, including progress monitoring and troubleshooting.
Membership
- Representatives from national trials group. - At least one statistician and one methodologist. - Ex officio: Chair of Translational Studies Committee for integration.
Leadership & Reporting
Chaired by a senior clinician-scientist elected by the Board for three years, 3-year term, renewable once by mutual agreement for two years. Reports to the HNCIG CEO.
Meetings
Minimum of three times per year (virtual/hybrid).
Deliverables
- Annual report on trial portfolio.
- Recommendations to the Board on trial endorsement.
Review
Reviewed every three years by the Board.
Committee Members